Risk Communication Regarding Drugs:The FDA Strategic Plan for Risk Communication-Reference-Cited by-同舟云学术

Risk Communication Regarding Drugs:The FDA Strategic Plan for Risk Communication

Published:2010 Issue:1 Volume:15 Page:11-21
ISSN:1342-0445
Container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
language:en
Short-container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku

Author:

YAMAMOTO Michiko¹²,HORIKI Wakako²,SUGIMORI Hiroki³,NAKAYAMA Takeo⁴

Affiliation:

1. Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science

2. Office of Safety 1, Pharmaceuticals and Medical Devices Agency

3. Department of Preventive Medicine, Graduate School of Sports and Health Science, Daito Bunka University

4. Department of Health Informatics, Kyoto University School of Public Health

Publisher

Japanese Society for Pharmacoepidemiology

Subject

General Medicine

Link

http://www.jstage.jst.go.jp/article/jjpe/15/1/15_1_11/_pdf

Reference17 articles.

1. 1) Guidance Drug Safety Information-FDA's Communication to the Public.http://www.fda.gov/cder/guidance/7477fnl.pdf (accessed 22 March, 2010)

2. 2) FDA's Strategic Plan for Risk Communication.http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UCM183683.pdf (accessed 22 March, 2010)

3. 3) Morgan MG. Fischhoff B, Bostrom A, Atman CJ. Risk Communication:A Mental Models Approach. Cambridge, England:Cambridge University Press. 2001:1-14.

4. 4) 山本美智子,宮田直樹.COX-2阻害薬の心血管系への安全性.日薬理誌.2008;133(2):115-6.

5. Risk Communication Regarding Drug Safety

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk/Benefit Communication: International Developments and Prospects for the Future;YAKUGAKU ZASSHI;2018-03-01

2. Risk Communication Efforts for Drug Safety in the US and EU, and Its Present Situation in Japan;YAKUGAKU ZASSHI;2012-05-01

3. Evaluation of Effectiveness of Risk Communication for Medication Therapy;Iryo To Shakai;2011